Vascular endothelial growth factor receptor 2 as a marker for malignant vascular tumors and mesothelioma: an immunohistochemical study of 262 vascular endothelial and 1640 nonvascular tumors
about
Expression of vascular endothelial growth factor receptor 2 (VEGFR-2), inducible nitric oxide synthase (iNOS), and Ki-M1P in skull base chordoma: a series of 145 tumors.Prognostic significance of immunohistochemical expression of VEGFR2 and iNOS in spinal chordoma.Emerging therapeutic targets for synovial sarcoma.The role of the VEGF-C/VEGFRs axis in tumor progression and therapy.Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lungFrequent truncating mutations of STAG2 in bladder cancer.Epithelioid peritoneal mesothelioma: a hybrid phenotype within a mesenchymal-epithelial/epithelial-mesenchymal transition framework.Doing more with less: New markers for sarcoma diagnosis and their applicability to cytology specimens.Sindbis Virus-Pseudotyped Lentiviral Vectors Carrying VEGFR2-Specific Nanobody for Potential Transductional Targeting of Tumor Vasculature.Littoral cell angioma of the spleen: a study of 25 cases with confirmation of frequent association with visceral malignancies.Histopathological vascular investigation of the peritumoral brain zone of glioblastomas.Nanoparticle-Cell Interaction: A Cell Mechanics Perspective.Increased tumor vascularization is associated with the amount of immune competent PD-1 positive cells in testicular germ cell tumors.Design, Synthesis and Biological Activity Evaluation of S-Substituted 1-5-Mercapto-1,2,4-Triazole Derivatives as Antiproliferative Agents in Colorectal CancerRadionuclide imaging of VEGFR2 in glioma vasculature using biparatopic affibody conjugate: proof-of-principle in a murine model
P2860
Q33274913-708B350C-33A3-4CDE-9557-1084590FBAECQ33275293-AFDE571E-27A1-4461-9B1B-6E46EDEE95AEQ34660607-4FA721CC-42CE-4DF9-A807-59878AE13954Q36589860-8E4FABBD-7C30-4685-8FE9-D07912FDB391Q37308766-C43767A7-AE16-492D-9E2D-38A7410F64B5Q37419131-F4741337-1441-4AD0-BAF8-1340B959B100Q37688972-C3B1E45D-F406-4EA5-86EC-A18B7E7EDF1CQ38700995-4E3DAA50-46FF-4986-9698-702EECBC37C9Q39372488-9BDE0E8C-5D35-4F94-9DA2-C216CEBFEFC9Q39635553-3C8E13AA-A00E-40AA-8C90-0B66CE38C4A5Q47943313-64A09805-3729-48A1-BEF7-704E46AEB21CQ48044144-ECB08797-38D4-4AAC-BA36-9755A4EBB3E3Q55263819-D41682FF-AF2F-42E9-90EB-9B0B8B9E3093Q57167787-D0F74CF7-B7E7-4A57-ACB6-1AA928C931E2Q58796699-FC3DF701-7303-4C33-9B83-BF10F143589B
P2860
Vascular endothelial growth factor receptor 2 as a marker for malignant vascular tumors and mesothelioma: an immunohistochemical study of 262 vascular endothelial and 1640 nonvascular tumors
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Vascular endothelial growth fa ...... al and 1640 nonvascular tumors
@ast
Vascular endothelial growth fa ...... al and 1640 nonvascular tumors
@en
Vascular endothelial growth fa ...... l and 1640 nonvascular tumors.
@nl
type
label
Vascular endothelial growth fa ...... al and 1640 nonvascular tumors
@ast
Vascular endothelial growth fa ...... al and 1640 nonvascular tumors
@en
Vascular endothelial growth fa ...... l and 1640 nonvascular tumors.
@nl
prefLabel
Vascular endothelial growth fa ...... al and 1640 nonvascular tumors
@ast
Vascular endothelial growth fa ...... al and 1640 nonvascular tumors
@en
Vascular endothelial growth fa ...... l and 1640 nonvascular tumors.
@nl
P2093
P2860
P1476
Vascular endothelial growth fa ...... al and 1640 nonvascular tumors
@en
P2093
Janusz Rys
Jerzy Lasota
Maarit-Sarlomo Rikala
Markku Miettinen
Zeng-Feng Wang
P2860
P304
P356
10.1097/PAS.0B013E318243555B
P407
P577
2012-04-01T00:00:00Z